Today: 18 July 2026
Browse Category

Stock Market 6 February 2026

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Hims & Hers (HIMS) stock slides premarket as FDA targets “copycat drugs” over $49 Wegovy pill

Shares of Hims & Hers Health dropped 3.8% to $23.48 in premarket trading on Friday. The slide came after FDA Commissioner Marty Makary warned the agency would act quickly against firms mass-marketing “illegal copycat drugs.” The stock had already fallen 3.8% on Thursday and plunged nearly 10% after hours, following Makary’s post on X stating, “The FDA cannot verify the quality, safety, or effectiveness of non-approved drugs.” His comments came after Hims introduced a compounded version of Novo Nordisk’s Wegovy weight-loss medication.
UK Stock Market Forecast 2026: FTSE 100 clings to rate-cut bets as AI jitters hit data stocks

UK Stock Market Forecast 2026: FTSE 100 clings to rate-cut bets as AI jitters hit data stocks

London’s FTSE 100 edged up on Friday as gains in major banks outweighed another drop from data analytics firm RELX, which continues to feel pressure amid the global AI selloff. The blue-chip index was 0.2% higher at 1133 GMT, eyeing a second consecutive weekly gain. The FTSE 250, meanwhile, barely moved and looks set to slip for a second week. Barclays, NatWest, and Lloyds climbed between 1% and 1.6%. RELX fell 3.5%. Fresnillo gained 1.8%, while Next added 0.5% after acquiring footwear brand Russell & Bromley via an insolvency deal.
Go toTop